ATAI
Price
$1.35
Change
-$0.05 (-3.55%)
Updated
Mar 11, 02:01 PM (EDT)
Capitalization
274.5M
16 days until earnings call
VNDA
Price
$4.71
Change
-$0.14 (-2.89%)
Updated
Mar 10 closing price
Capitalization
274.96M
50 days until earnings call
Ad is loading...

ATAI vs VNDA

Header iconATAI vs VNDA Comparison
Open Charts ATAI vs VNDABanner chart's image
ATAI Life Sciences
Price$1.35
Change-$0.05 (-3.55%)
Volume$100
Capitalization274.5M
Vanda Pharmaceuticals
Price$4.71
Change-$0.14 (-2.89%)
Volume$435.65K
Capitalization274.96M
ATAI vs VNDA Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. VNDA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and VNDA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ATAI: $1.41 vs. VNDA: $4.71)
Brand notoriety: ATAI and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 70% vs. VNDA: 64%
Market capitalization -- ATAI: $274.5M vs. VNDA: $274.96M
ATAI [@Biotechnology] is valued at $274.5M. VNDA’s [@Biotechnology] market capitalization is $274.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATAI and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 5 bearish.
  • VNDA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ATAI and VNDA are a bad buy in the short-term.

Price Growth

ATAI (@Biotechnology) experienced а -6.00% price change this week, while VNDA (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.06%. For the same industry, the average monthly price growth was -9.70%, and the average quarterly price growth was -9.16%.

Reported Earning Dates

ATAI is expected to report earnings on May 20, 2025.

VNDA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-1.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($275M) and ATAI($274M) have the same market capitalization . ATAI YTD gains are higher at: 6.015 vs. VNDA (0.418). VNDA has higher annual earnings (EBITDA): -32.53M vs. ATAI (-124.33M). VNDA has more cash in the bank: 375M vs. ATAI (85.9M). VNDA has less debt than ATAI: VNDA (12.4M) vs ATAI (23.8M). VNDA has higher revenues than ATAI: VNDA (199M) vs ATAI (331K).
ATAIVNDAATAI / VNDA
Capitalization274M275M100%
EBITDA-124.33M-32.53M382%
Gain YTD6.0150.4181,441%
P/E RatioN/A137.00-
Revenue331K199M0%
Total Cash85.9M375M23%
Total Debt23.8M12.4M192%
FUNDAMENTALS RATINGS
ATAI vs VNDA: Fundamental Ratings
ATAI
VNDA
OUTLOOK RATING
1..100
818
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5853
P/E GROWTH RATING
1..100
132
SEASONALITY SCORE
1..100
7839

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATAI's Valuation (81) in the Miscellaneous Commercial Services industry is in the same range as VNDA (85) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

ATAI's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VNDA (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

ATAI's SMR Rating (100) in the Miscellaneous Commercial Services industry is in the same range as VNDA (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's Price Growth Rating (53) in the Biotechnology industry is in the same range as ATAI (58) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is in the same range as ATAI (13) in the Miscellaneous Commercial Services industry. This means that VNDA’s stock grew similarly to ATAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIVNDA
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 8 days ago
79%
Bearish Trend 8 days ago
80%
Momentum
ODDS (%)
Bearish Trend 8 days ago
79%
Bullish Trend 8 days ago
73%
MACD
ODDS (%)
Bearish Trend 8 days ago
77%
Bullish Trend 8 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 8 days ago
84%
Bullish Trend 8 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
83%
Bullish Trend 8 days ago
73%
Advances
ODDS (%)
Bullish Trend 29 days ago
80%
Bullish Trend 14 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 16 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
84%
Bearish Trend 8 days ago
78%
Aroon
ODDS (%)
Bullish Trend 8 days ago
83%
Bearish Trend 8 days ago
77%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with FATE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-6.62%
FATE - ATAI
48%
Loosely correlated
-8.24%
MNMD - ATAI
46%
Loosely correlated
-7.76%
RXRX - ATAI
40%
Loosely correlated
-6.98%
CRSP - ATAI
39%
Loosely correlated
-4.81%
ABOS - ATAI
38%
Loosely correlated
-4.00%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IKNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+1.91%
IKNA - VNDA
37%
Loosely correlated
+4.65%
SNGX - VNDA
32%
Poorly correlated
N/A
ATRA - VNDA
30%
Poorly correlated
+1.86%
CLDX - VNDA
29%
Poorly correlated
+3.36%
FHTX - VNDA
28%
Poorly correlated
+1.62%
More